Cardiovascular Disease Prevention

Prevention of Heart Failure With Non-pharmacological Interventions

by Prateek Chopra | May 21, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure (HF) prevention increasingly focuses on early modification of upstream cardiometabolic risk factors through lifestyle and dietary interventions. Emerging evidence suggests that non-pharmacological strategies targeting hypertension, obesity, diabetes, physical inactivity, and adverse dietary patterns may significantly reduce future HF risk, particularly heart failure with preserved ejection fraction

Prevention of Heart Failure With Non-pharmacological Interventions Read Post »

Leave a Comment / ESC-HF Day 2 / / / , , , ,

Managing the Complex Hypertensive Patients in a Multi-Morbid World

by Prateek Chopra | June 14, 2026 | Cardiology Conferences | ESH 2026 Research Objective: Examine the epidemiological burden of multimorbidity in hypertension, the interplay between HTN and common comorbidities, and evidence-based strategies for cardiovascular risk reduction in complex hypertensive patients. Study Context: Evidence and Data Sources: Patient Profile and Key Findings: Management requires individualized, goal-directed therapy focused on reducing cardiovascular

Managing the Complex Hypertensive Patients in a Multi-Morbid World Read Post »

Leave a Comment / ESH Day 3 / / / , , , ,

Immunization and Cardiovascular Protection: Evidence andFuture Directions

by Prateek Chopra | June 12, 2026 | Cardiology Conferences | ESH 2026 Clinical Rationale: Growing evidence supports a bidirectional relationship between infections and cardiovascular disease (CVD). Respiratory infections can trigger acute cardiovascular events and exacerbate pre-existing conditions, while patients with underlying CVD are at higher risk of severe infectious outcomes. Influenza infection, for example, increases the incidence of acute myocardial

Immunization and Cardiovascular Protection: Evidence andFuture Directions Read Post »

Leave a Comment / ESH Day 3 / / / , , , ,

Triple SPCs: Simplifying Treatment, Strengthening Control

by Prateek Chopra | June 8, 2026 | Cardiology Conferences | ESH 2026 Simplifying Hypertension Care: Despite hypertension being a leading contributor to cardiovascular morbidity and mortality, BP control remains suboptimal due to poor adherence, therapeutic inertia, and complex multi-drug regimens. Triple single-pill combinations (SPCs) simplify therapy, improve adherence, accelerate BP target attainment, and enhance long-term cardiovascular outcomes. Guideline-Based Recommendations: Real-World

Triple SPCs: Simplifying Treatment, Strengthening Control Read Post »

Leave a Comment / ESH Day 2 / / / , , , ,

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome?

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESH 2026 Study Objective: Evaluate whether lifestyle interventions can prevent progression of cardiac damage across different stages of CKM syndrome. Evidence Across CKM Stages: Stage 0 (Pre-risk / Children): Stage 2 (Metabolic Risk / Subclinical Disease): Stage 3 (Silent Cardiac Damage): Stage 4 (Established CVD / Secondary Prevention): Clinical Implications

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome? Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,
Scroll to Top